Objective: Among the mechanisms proposed for the development of bronchopulmonary
dysplasia is the increase in the pulmonary inflammatory process and oxidative stress. Thus …

Objective This study aimed to compare the safety and efficacy of intratracheal administration
of budesonide and surfactant with surfactant alone for bronchopulmonary dysplasia (BPD) …

Objective This study aimed to determine the effect of intratracheal instillation of a
budesonide–surfactant combination on the incidence of bronchopulmonary dysplasia (BPD) …

Objective To address the effectiveness and safety of early airway combined utilization of
budesonide and surfactant for bronchopulmonary dysplasia (BPD) prevention in premature …

Background: Neonatal acute respiratory distress syndrome (NARDS) is an important cause
of hypoxemic respiratory failure. This study aimed to investigate the short-term effects of …

Background: Pulmonary inflammation plays a critical role in the pathogenesis of respiratory
distress syndrome. The aim of this study was to compare the effectiveness of intratracheal …

Background: The combination of surfactant and budesonide has been shown to decrease
BPD rates and severity. Budesonide may be released systemically from lungs, and the …

Background Respiratory distress syndrome (RDS) is one of the most important and common
disorders among premature infants. Objective This study aimed to compare the effect of the …

This research addresses the respiratory distress syndrome (RDS) in preterm newborns
caused by insufficient surfactant synthesis, which can lead to serious complications …

布地奈德联合肺表面活性物质气管内给药预防支气管肺发育不良的前瞻性随机对照研究- PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …